BIOCORP and SANOFI Announce a Partnership to Fit SoloStar Insulin Pens With Mallya Technology Worldwide
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, announces today the signature of a worldwide partnership agreement with SANOFI for the use of Mallya technology, a connected device for insulin pens.
This long-term agreement is the first decision resulting from exclusive negotiations initiated in July 2019. SANOFI and BIOCORP are thus fulfilling today their ambition to enter into a long-term partnership in the diabetes area.
The agreement covers two main points:
- Sanofi acquires the rights to a non-exclusive distribution of Mallya in its current version worldwide, starting in 2020.
- BIOCORP is committed to develop a specific and exclusive version of Mallya for SoloStar, SANOFI's insulin pen.
As a result of the agreement, Sanofi is to pay BIOCORP a further €2 million upon signature of the contract (last July, BIOCORP received a first payment of €4 million). In addition, a third payment of €1.5 million is expected in 2020 when Mallya is effectively launched on the market.
BIOCORP will produce the Mallya devices at its production plant in Issoire, France.
Éric Dessertenne, Chief Operating Officer of BIOCORP, commented: "The expected and now confirmed signature of this contract provides a huge satisfaction to BIOCORP’s team. It confirms the promise of a long and successful partnership with SANOFI. As previously mentioned, Mallya has the potential to be a blockbuster thanks to the competitive advantages it brings to patients in monitoring the follow-up of their diabetes. Thanks to SANOFI's global reach, this device will help improve compliance for the largest number of patients with diabetes. We are pleased to have our expertise recognized by a world leader in Life Sciences and are convinced that this is only the first step in Mallya's history."
ABOUT BIOCORP
Founded in 2004 in Issoire (near Clermont-Ferrand), France, BIOCORP is a French company specializing in the development and manufacturing of medical devices and innovative drug delivery systems. It is listed as ‘Innovative Company’ by the French public investment bank Bpifrance. With over twenty years of experience and more than 30 manufactured products, BIOCORP is a key player in the industry, providing drug delivery solutions that meet the evolving needs of patients. Today, BIOCORP continues to innovate in medical plastics, its core business, and to market traditional devices (alternative to aluminum capsules, syringe and vial administration systems) that have been an important source of recurring income. Its solid expertise and capacity to innovate have allowed the company to develop new Internet-connected products, including MallyaTM, a smart cap for pen injectors that captures injection data and automatically transmits data to a mobile app, helping patients to manage their treatment. The company has a team of 45 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com
Follow us on Twitter @BIOCORPSystems
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191211005828/en/
Contact information
BIOCORP
Jacques Gardette
CEO
Éric Dessertenne
Chief Operating Officer
Sylvaine Dessard
Marketing & Communication Director
investisseurs@biocorp.fr
rp@biocorp.fr
+ 33 (0)6 88 69 72 85
ULYSSE COMMUNICATION
Bruno ARABIAN
barabian@ulysse-communication.com
+33 (0)6 87 88 46 26
Nicolas DANIELS
ndaniels@ulysse-communication.com
+33 (0)6 63 66 59 22
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cannatrol, Creators of Breakthrough Postharvest Cannabis Technology, Receive Two European Patent Approvals25.4.2024 14:03:00 CEST | Press release
Cannatrol, the creators of the only total dry, cure and store system for the cannabis industry, announced today the approval of two European patents for its Vaportrol® Technology, protecting the proprietary technology throughout the European Union. “As the European cannabis industry grows, demand for precision drying, curing and storage technologies continues to expand,” said David Sandelman, co-founder, COO and CTO of Cannatrol. “Cannatrol’s proven environmental-control system ensures top-quality cannabis through a repeatable, consistent process, and it’s appropriate for any scale of cultivation, from large-scale greenhouse production to home growers.” Cannatrol’s patented postharvest technology is proven to increase yields and curing efficiency, and delivers on average 16% higher terpene retention when compared to traditional drying and curing methods, according to independent testing by The Cannabis Research Coalition. Throughout drying, curing and storage, the environment will stay
Visa Joins AWS Partner Network to Help Simplify Global Digital Payments25.4.2024 14:00:00 CEST | Press release
Visa (NYSE: V), a world leader in global digital payments, announced today it has joined the AWS Partner Network (APN), a global community that leverages AWS technologies, programs, expertise, and tools to build solutions and services for customers. Visa’s presence in the APN will help enable its partners and clients, including cloud-native fintechs, to access and integrate select Visa services more efficiently. Global Payments Simplified Visa is committed to making transactions faster, easier and more secure for all players in the payments ecosystem. Visa will make select payment services available in the AWS Marketplace, which has more than 300,000 global customers and thousands of software listings. By making its services available in AWS, Visa is meeting its clients where they are. One of the first services to be available is Visa Cross-Border Solutions, which assists in streamlining the process of sending and receiving money globally and holding multiple currencies. This strategic
Edgio Releases Client-Side Protection to Help Protect Users’ Data Against Malicious Scripts25.4.2024 14:00:00 CEST | Press release
Edgio, the platform of choice for security, speed and simplicity at the edge, today announced the release of its Client-Side Protection solution. Designed to monitor scripts and APIs on the browser-side to prevent malicious code from exfiltrating sensitive customer data, Edgio Client-Side Protection allows teams to gain full visibility on client-side vulnerabilities, achieve full control over all first- and third-party resources and maintain the latest compliance requirements. Payment Card Industry (PCI) Data Security Standard (DSS) v4.0 represents the latest global standards for protecting payment data against sophisticated cyber attacks. PCI DSS v4.0 reflects the latest needs of the payments industry as threats evolve, including damaging Magecart attacks, a type of digital credit card skimming. With Magecart skimmers spotted in over 2 million websites, organizations must prioritize proactively protecting customer data based on a comprehensive understanding of the scripts and external
Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study25.4.2024 13:50:00 CEST | Press release
AMRA Medical, a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms, in collaboration with Linköping University, is pleased to announce the completion of baseline enrollment for the innovative ACCESS-ESLD (A Rapid, Non-invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal HypertenSion, and Hepatocellular Carcinoma in End-Stage Liver Disease) study. The nationally-comprised study population includes 150 liver cirrhosis patients aged 18 and up, with no liver transplant history or contraindications to performing an MRI examination, enrolled from one of three Swedish liver care clinics located in Linköping, Eksjö, or Jönköping. Over a duration of 2 years, patients will be assessed every 6 months with a comprehensive clinical examination and a whole-body MRI examination. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240425020
Geopolitical Unrest Generates an Onslaught of DDoS Attacks, According to the Latest NETSCOUT Threat Intelligence Report25.4.2024 12:05:00 CEST | Press release
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) today released findings from its 2H2023 DDoS Threat Intelligence Report that dissects trends and attack methodologies adversaries use against service providers, enterprises, and end-users. The information cited in the report is gathered from NETSCOUT’s unparalleled internet visibility at a global scale, collecting, analyzing, prioritizing, and disseminating data on DDoS attacks from 214 countries and territories, 456 vertical industries, and more than 13,000 Autonomous System Numbers (ASNs). Driven by tech-savvy and politically motivated hacktivist groups and an increase in DNS water torture attacks, NETSCOUT observed more than 7 million DDoS attacks in the second half of 2023, representing a 15% increase from the first half. Hacktivism Increases Ten-Fold DDoS (Distributed Denial-of-Service) hacktivism transcended geographic borders during the past year, exemplifying a shift in the global security landscape. Groups like NoName057(016) and Anonymous